Research > ETFs > ETF / ETP Commentary > 

Top Performing Leveraged/Inverse ETFs: 08/23/2026

Top Performing Leveraged/Inverse ETFs Last WeekThese were last week’s top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly. Always do your homework.1. TEMT – Tradr 2X Long TEM Daily ETF TEMT ETF, which provides 2x exposure to the daily price movement of Tempus AI Inc. (TEM) stock topped the list with over 85% weekly gains. Tempus, the healthcare AI stock climbed last week due to positive clinical trial results from Merck and Moderna and bullish analyst activity. 2. XRPT – Volatility Shares Trust XRP 2X ETF XRPT, an actively managed fund, offering 2x the daily price participation in XRP using near-term futures and XRP-linked instruments, ranked second on the list returning ~83% in the last week. XRP ETF gained last week because of a massive surge in institutional inflows, a broader crypto market rally driven by U.S. Treasury policies, and major institutional disclosures like Goldman Sachs building large holdings. 3. ETHU – 2x Ether ETF ETHU ETF, which aims to provide 2x the daily price movements of Ether, made it to the Levered/ Inverse ETFs’ list with over 61% weekly gains. Ether prices surged last week due to a mix of higher market liquidity, political optimism, and strong institutional buying. 4. ETHT – ProShares Ultra Ether ETF ETHT, which tracks 2x the daily price movements of an index that measures the price of Ether, also featured on the list with over 61% weekly returns fueled by growing political optimism, and robust institutional inflows. 5. ETU – T-Rex 2X Long Ether Daily Target ETF ETU which aims to provide 2x leveraged exposure to the daily price movement of spot Ether (ETH) was another contender on the list with ~60% weekly gains. 6. MSTP – GraniteShares 2x Long MSTR Daily ETF MSTP was another candidate on the top levered ETFs list last week. It provides 2x leveraged exposure to the daily price movement for shares of Strategy stock, which gained last week due to a powerful surge in Bitcoin prices, a massive crypto short squeeze, and a large capital raise that built a multi-billion-dollar liquidity pool. 7. MSTX – Defiance Daily Target 2x Long MSTR ETF MSTX, which seeks to provide 2x leveraged exposure to the daily share price movement of Strategy Inc. (NYSE: MSTR), also made it to the list with ~59% returns in the last week. 8. MSTU – T-Rex 2X Long MSTR Daily Target ETF MSTU, which aims to provide 2x leveraged exposure to the daily price movement of Strategy Inc. stock (NASDAQ: MSTR), was present on the list. Strategy shares increased last week, driven by Bitcoin’s sharp upswing, an aggressive crypto short squeeze, and a large liquidity buffer built through a major capital raise. 9. CONL – GraniteShares 2x Long COIN Daily ETF CONL ETF, which provides 2x leveraged exposure to the daily price movement for shares of Coinbase stock, was present on the list with over 53% weekly returns. Coinbase (NASDAQ: COIN) stock gained last week due to a strong surge in Bitcoin prices, a massive short squeeze, and high-level regulatory optimism in Washington. 10. BITX – Volatility Shares 2X Bitcoin ETF BITX, which seeks daily investment results, before fees and expenses, that correspond to two times the excess return of the S&P CME Bitcoin Futures Daily Roll Index, was another candidate on the list of leveraged ETFs with over 48% returns last week. Bitcoin gained last week due to a mix of U.S. Treasury bond actions, regulatory optimism, a massive short squeeze, and large institutional inflows. For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.